Trial Profile
Apatinib mesylate tablets in the treatment of refractory soft tissue sarcoma stage II, open single arm pilot study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 26 Apr 2016 New trial record